Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FADTH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,540
Award facts
- Contract value 100% obligated
- $63,539.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $63,539.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick autoinjector pens. The award was made on January 9, 2026, with an ultimate completion date of January 12, 2026, and no set-aside designation was applied. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company, Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary pharmaceutical supply vehicle for military healthcare programs globally.
Repatha (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol in patients with cardiovascular disease or familial hypercholesterolemia. This delivery order reflects the Defense Logistics Agency's role in procuring pharmaceutical products to support military treatment facilities and veteran healthcare systems. As a non-competitive delivery order under an established IDC, this award demonstrates AmerisourceBergen's continued role as a critical pharmaceutical distributor for federal military medical supply needs, with the company's comprehensive contract portfolio encompassing specialty medications, brand-name drugs, and critical medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FADTH?
SPE2DR26FADTH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FADTH worth?
The government has obligated $63,540 on SPE2DR26FADTH.
Is contract SPE2DR26FADTH an order under another contract?
Yes. SPE2DR26FADTH is a delivery order under SPE2DR25D2011, an indefinite delivery contract.
Was contract SPE2DR26FADTH competed?
The extent of competition for SPE2DR26FADTH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award